Quest diagnostics completes acquisition of select pathai diagnostics' lab assets from pathai, accelerating adoption of ai and digital pathology to speed cancer diagnosis

Pathai remains an independent company, focused on developing innovative ai and digital pathology solutions secaucus, n.j. and boston , june 11, 2024 /prnewswire/ -- quest diagnostics (nyse: dgx), a leader in diagnostic information services, today announced that it has completed its previously announced acquisition of pathai diagnostics from pathai, with the goal to accelerate the adoption of ai and digital pathology to improve the diagnosis of cancer and other diseases.
DGX Ratings Summary
DGX Quant Ranking